Cholera toxin

Cholera toxin mechanism

Cholera toxin (also known as choleragen and sometimes abbreviated to CTX, Ctx or CT) is an AB5 multimeric protein complex secreted by the bacterium Vibrio cholerae.[1][2] CTX is responsible for the massive, watery diarrhea characteristic of cholera infection.[3] It is a member of the heat-labile enterotoxin family.

History

Robert Koch, a German physician and microbiologist, was the first person to postulate the existence of cholera toxin. In 1886, Koch proposed that Vibrio cholerae secreted a substance which caused the symptoms of cholera.[4] Koch's postulation was proven correct by Indian microbiologist Sambhu Nath De, who in 1951 studied and documented the effects of injecting rabbits with heat-killed cholera bacteria.[5] He concluded from this experiment that an endotoxin liberated upon disintegration of the bacteria was the cause of the symptoms of cholera.[5] In 1959, De conducted another experiment, this time using a bacteria-free culture filtrate from V. cholerae injected into the small intestines of rabbits.[6] The resulting build up of fluid in the intestines conclusively proved the existence of a toxin.[7]

Structure

Cholera toxin B pentamer, Vibrio cholerae

The complete toxin is a hexamer made up of a single copy of the A subunit (part A, enzymatic, P01555), and five copies of the B subunit (part B, receptor binding, P01556), denoted as AB5. Subunit B binds while subunit A activates the G protein which activates adenylate cyclase. The three-dimensional structure of the toxin was determined using X-ray crystallography by Zhang et al. in 1995.[8]

The five B subunits—each weighing 11 kDa, form a five-membered ring. The A subunit which is 28 kDa, has two important segments. The A1 portion of the chain (CTA1) is a globular enzyme payload that ADP-ribosylates G proteins, while the A2 chain (CTA2) forms an extended alpha helix which sits snugly in the central pore of the B subunit ring.[9]

This structure is similar in shape, mechanism, and sequence to the heat-labile enterotoxin secreted by some strains of the Escherichia coli bacterium.

Pathogenesis

Cholera toxin acts by the following mechanism: First, the B subunit ring of the cholera toxin binds to GM1 gangliosides on the surface of target cells. If a cell lacks GM1, the toxin most likely binds to other types of glycans, such as Lewis Y and Lewis X, attached to proteins instead of lipids.[10][11][12] Once bound, the entire toxin complex is endocytosed by the cell and the reduction of a disulfide bridge releases the cholera toxin A1 (CTA1) chain. The endosome is moved to the Golgi apparatus, where the A1 protein is recognized by the endoplasmic reticulum (ER) chaperone, protein disulfide isomerase. The A1 chain is then unfolded and delivered to the membrane, where Ero1 triggers the release of the A1 protein by oxidation of protein disulfide isomerase complex.[13] As the A1 protein moves from the ER into the cytoplasm by the Sec61 channel, it refolds and avoids deactivation as a result of ubiquitination.

CTA1 is then free to bind with a human partner protein called ARF6 (ADP-ribosylation factor 6); binding to Arf6 drives a change in the shape of CTA1 which exposes its active site and enables its catalytic activity.[14] The CTA1 fragment catalyses ADP-ribosylation of the Gs alpha subunit (Gαs) proteins using NAD. The ADP-ribosylation causes the Gαs subunit to lose its catalytic activity of GTP hydrolysis into GDP + Pi, thus maintaining Gαs in its activated state. Increased Gαs activation leads to increased adenylate cyclase activity, which increases the intracellular concentration of 3',5'-cyclic AMP (cAMP) to more than 100-fold over normal and over-activates cytosolic PKA. These active PKA then phosphorylate the cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel proteins, which leads to ATP-mediated efflux of chloride ions and leads to secretion of H2O, Na+, K+, and HCO3− into the intestinal lumen. In addition, the entry of Na+ and consequently the entry of water into enterocytes are diminished. The combined effects result in rapid fluid loss from the intestine, up to 2 liters per hour, leading to severe dehydration and other factors associated with cholera, including a rice-water stool.[15]

The pertussis toxin (also an AB5 protein) produced by Bordetella pertussis acts in a similar manner with the exception that it ADP-ribosylates the Gαi subunit, rendering it unable to inhibit cAMP production.[16]

Origin

The gene encoding the cholera toxin was introduced into V. cholerae by horizontal gene transfer. Virulent strains of V. cholerae (the O1 and O139 serogroups) hold genes from a virus known as the CTXφ bacteriophage.[17] The integrated CTXφ genome contains many of the genes of RS1, a filamentous "satellite" phage, including elements for replication (RstA), integration (RstB), preventing repression of CTXφ replication (RstC) and regulation of gene expression (RstR), as well as genes coding for proteins needed for phage packaging and secretion (Psh, Cep, OrfU, Ace and Zot), which are very similar to the genes of Ff filamentous coliphages.[17] These genes (and others) enable the replication and later secretion of the CTXφ bacteriophage, facilitating the horizontal gene transfer of CTXφ to other susceptible cells without requiring excision of the prophage from the original host bacterium, transmitting the gene encoding CTX together with the remainder of the phage genome.[17]

Applications

Because the B subunit appears to be relatively non-toxic, researchers have found a number of applications for it in cell and molecular biology. It is routinely used as a neuronal tracer.[18]

Treatment of cultured rodent neural stem cells with cholera toxin induces changes in the localization of the transcription factor Hes3 and increases their numbers.[19]

GM1 gangliosides are found in lipid rafts on the cell surface. B subunit complexes labelled with fluorescent tags or subsequently targeted with antibodies can be used to identify rafts.

Vaccine

There are currently two vaccines for cholera: Dukoral and Shanchol. Both vaccines use whole killed V. cholerae cells however, Dukoral also contains recombinant cholera toxin β (rCTB). Some studies suggest that the inclusion of rCTB may improve vaccine efficacy in young children (2-10) and increase the duration of protection. This is countered by the costs of protecting and storing rCTB against degradation.[20]

Vaccine adjuvant

Another application of the CTB subunit may be as a vaccine adjuvant to other vaccines. It has been shown that coupling CTB and antigens improves the response of the vaccine. Currently the adjuvant potential of CTB has been shown in large animal models so further research is needed. This may allow for CTB to be used as an adjuvant for vaccinating against many kinds of diseases. This may include bacterial and viral infections, allergy and diabetes. Of note, as CTB has shown to induce mucosal humoral immune responses, vaccines against mucosal viruses such as HIV are a potential target.[20]

Membrane biology

Lipid rafts

Since cholera toxin has been shown to preferentially bind to GM1 gangliosides, this characteristic can be utilized for membrane studies. Lipid rafts are difficult to study as they vary in size and lifetime, as well being part of an extremely dynamic component of cells. Using cholera toxin β as a marker, we can get a better understanding of the properties and functions of lipid rafts.[21]

Endocytosis

Endocytosis is broadly divided into clathrin-dependent and clathrin-independent process, and the cholera toxin utilizes both pathways. Cholera toxin has been shown to enter cells via endocytosis in multiple pathways. These pathways include caveolae, clathrin-coated pits, clathrin-independent carriers (CLICs), and GPI-Enriched Endocytic Compartments (GEECs) pathway, ARF6-mediated endocytosis and Fast Endophilin-Mediated Endocytosis (FEME). How cholera toxin triggers these endocytosis pathways is not fully understood, but the fact that cholera toxin triggers these pathways shows the use of the toxin as an important marker to investigate these mechanisms.[21]

Retrograde trafficking

One of the most important aspects of cholera toxin is the retrograde traffic mechanism that transports the toxin from the cell membrane back to the trans-Golgi network and the endoplasmic reticulum. Since both cholera toxin and GM1 species can be tagged with a fluorescent tags, the mechanism of retrograde traffic can be monitored. This opens up the potential to monitor the mechanism in real time. This may open up new discoveries on how intracellular transport works and how protein and lipid sorting work in the endocytotic pathway.[21]

See also

References

  1. ^ Ryan KJ; Ray CG, eds. (2004). Sherris Medical Microbiology (4th ed.). McGraw Hill. p. 375. ISBN 978-0-8385-8529-0.
  2. ^ Faruque, Shah M; Nair, G. Balakrish, eds. (July 2008). Vibrio cholerae: Genomics and Molecular Biology. Caister Academic Press. ISBN 978-1-904455-33-2.
  3. ^ Aizpurua-Olaizola, Oier; Sastre Torano, Javier; Pukin, Aliaksei; Fu, Ou; Boons, Geert Jan; de Jong, Gerhardus J.; Pieters, Roland J. (2018). "Affinity capillary electrophoresis for the assessment of binding affinity of carbohydrate-based cholera toxin inhibitors". Electrophoresis. 39 (2): 344–347. doi:10.1002/elps.201700207. ISSN 1522-2683. PMID 28905402. S2CID 33657660.
  4. ^ Bharati, Kaushik; Ganguly, Nirmal K. (February 2011). "Cholera toxin: A paradigm of a multifunctional protein". The Indian Journal of Medical Research. 133 (2): 179–187. ISSN 0971-5916. PMC 3089049. PMID 21415492.
  5. ^ a b De, S. N.; Sarkar, J. K.; Tribedi, B. P. (1951). "An experimental study of the action of cholera toxin". The Journal of Pathology and Bacteriology. 63 (4): 707–717. doi:10.1002/path.1700630417. PMID 14898376.
  6. ^ De, S. N. (1959-05-30). "Enterotoxicity of bacteria-free culture-filtrate of Vibrio cholerae". Nature. 183 (4674): 1533–1534. doi:10.1038/1831533a0. ISSN 0028-0836. PMID 13666809.
  7. ^ Bharati, Kaushik; Ganguly, Nirmal K. (February 2011). "Cholera toxin: A paradigm of a multifunctional protein". The Indian Journal of Medical Research. 133 (2): 179–187. ISSN 0971-5916. PMC 3089049. PMID 21415492.
  8. ^ Zhang R, Scott D, Westbrook M, Nance S, Spangler B, Shipley G, Westbrook E (1995). "The three-dimensional crystal structure of cholera toxin". J Mol Biol. 251 (4): 563–73. doi:10.1006/jmbi.1995.0456. PMID 7658473.
  9. ^ De Haan L, Hirst TR (2004). "Cholera toxin: a paradigm for multi-functional engagement of cellular mechanisms (Review)". Mol. Membr. Biol. 21 (2): 77–92. doi:10.1080/09687680410001663267. PMID 15204437. S2CID 22270979.
  10. ^ Amberlyn M Wands; Akiko Fujita (October 2015). "Fucosylation and protein glycosylation create functional receptors for Cholera toxin". eLife. 4: e09545. doi:10.7554/eLife.09545. PMC 4686427. PMID 26512888.
  11. ^ Cervin J, Wands AM, Casselbrant A, Wu H, Krishnamurthy S, Cvjetkovic A, et al. (2018). "GM1 ganglioside-independent intoxication by Cholera toxin". PLOS Pathogens. 14 (2): e1006862. doi:10.1371/journal.ppat.1006862. PMC 5825173. PMID 29432456.
  12. ^ Wands AM, Cervin J, Huang H, Zhang Y, Youn G, Brautigam CA, Matson Dzebo M, Björklund P, Wallenius V, Bright DK, Bennett CS, Wittung-Stafshede P, Sampson NS, Yrlid U, Kohler JJ (February 7, 2018). "Fucosylated Molecules Competitively Interfere with Cholera Toxin Binding to Host Cells". ACS Infectious Diseases. 4 (5): 758–770. doi:10.1021/acsinfecdis.7b00085. PMC 5948155. PMID 29411974.
  13. ^ Tsai, Billy; Rapoport, Tom A. (2002). "Unfolded cholera toxin is transferred to the ER membrane and released from protein disulfide isomerase upon oxidation by Ero1". Journal of Cell Biology. 159 (2): 207–216. doi:10.1083/jcb.200207120. PMC 2173060. PMID 12403808. S2CID 3111310.
  14. ^ O'Neal C, Jobling M, Holmes R, Hol W (2005). "Structural basis for the activation of cholera toxin by human ARF6-GTP". Science. 309 (5737): 1093–6. Bibcode:2005Sci...309.1093O. doi:10.1126/science.1113398. PMID 16099990. S2CID 8669389.
  15. ^ Joaquín Sánchez; Jan Holmgren (February 2011). "Cholera toxin – A foe & a friend" (PDF). Indian Journal of Medical Research. 133: 158. Archived from the original (PDF) on 2013-02-03. Retrieved 2013-06-09.
  16. ^ Boron, W. F., & Boulpaep, E. L. (2009). Medical physiology: a cellular and molecular approach (2nd ed.). Philadelphia, Pennsylvania: Saunders/Elsevier.
  17. ^ a b c Davis, Brigid M; Waldor, Matthew K (2003-02-01). "Filamentous phages linked to virulence of Vibrio cholerae". Current Opinion in Microbiology. 6 (1): 35–42. doi:10.1016/S1369-5274(02)00005-X. ISSN 1369-5274. PMID 12615217.
  18. ^ Pierre-Hervé Luppi. "The Discovery of Cholera-Toxin as a Powerful Neuroanatomical Tool". Retrieved 2011-03-23.
  19. ^ Androutsellis-Theotokis A, Walbridge S, Park DM, Lonser RR, McKay RD (2010). "Cholera toxin regulates a signaling pathway critical for the expansion of neural stem cell cultures from the fetal and adult rodent brains". PLOS ONE. 5 (5): e10841. Bibcode:2010PLoSO...510841A. doi:10.1371/journal.pone.0010841. PMC 2877108. PMID 20520777.
  20. ^ a b Baldauf, Keegan; Royal, Joshua; Hamorsky, Krystal; Matoba, Nobuyuki (2015). "Cholera Toxin B: One Subunit with Many Pharmaceutical Applications". Toxins. 7 (3): 974–996. doi:10.3390/toxins7030974. PMC 4379537. PMID 25802972.
  21. ^ a b c Kenworthy, Anne K.; Schmieder, Stefanie S.; Raghunathan, Krishnan; Tiwari, Ajit; Wang, Ting; Kelly, Christopher V.; Lencer, Wayne I. (2021). "Cholera Toxin as a Probe for Membrane Biology". Toxins. 13 (8): 543. doi:10.3390/toxins13080543. PMC 8402489. PMID 34437414.